Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXA2ZK
|
||||
| Drug Name |
N-{(S)-1-[2-(4-Methoxy-phenylamino)-ethylcarbamoyl]-2-phenyl-ethyl}-3-methyl-benzamide
|
||||
| Synonyms |
CHEMBL380989
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H29N3O3
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](Cc2ccccc2)NC(=O)c3cccc(C)c3)cc1
|
||||
| InChI |
InChI=1S/C26H29N3O3/c1-19-7-6-10-21(17-19)25(30)29-24(18-20-8-4-3-5-9-20)26(31)28-16-15-27-22-11-13-23(32-2)14-12-22/h3-14,17,24,27H,15-16,18H2,1-2H3,(H,28,31)(H,29,30)/t24-/m0/s1
|
||||
| InChIKey |
ALJVNNGOBYCHCX-DEOSSOPVSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.